Strengthening Clinical Trial Ethics and Regulatory Oversight in Africa: Lessons from TRACE
The Trial Regulatory and Clinical Ethics Optimization (TRACE) project is accelerating efforts to reform clinical trial ethics and regulatory oversight across Sub-Saharan Africa, according to reports published in Nature Medicine on September 7, 2026.
Expanding Footprint Across Sub-Saharan Africa
Key Clinical Takeaways:
- The TRACE project expanded its operational footprint in 2026 to include Kenya alongside foundational partners Nigeria, Rwanda, Zimbabwe, and Tanzania.
- Technical leadership is provided by the MRCT Center, focusing on harmonized ethics committee accreditation, in-country reliance models, and parallel regulatory submissions.
- A core operational benchmark of the initiative is achieving national ethics committee protocol review and approval within 60 days of initial submission.
Confronting Systemic Delays in Harare
Clinical research infrastructure across developing regions often faces systemic delays stemming from fragmented review pathways and isolated institutional review boards (IRBs). To evaluate the scope of these operational challenges, the TRACE core team convened in early June 2026 for a four-day meeting in Harare, Zimbabwe.
Hosted by the Medicines Control Authority of Zimbabwe (MCAZ), the gathering featured opening remarks from MCAZ leadership and the Gates Foundation, alongside a keynote address delivered by Dr. Aspect Jacob Vengani Maunganidze, Permanent Secretary for the Ministry of Health and Child Care in Zimbabwe. Participating nations used the summit to report concrete progress against project milestones, addressing the intricate friction points between ethics committees and national regulatory bodies.
Operational Readiness and Digital Tracking
Day one of the Harare summit concentrated heavily on institutional readiness, evaluating how participating countries can meet the stringent target of completing protocol reviews within 60 days.
Day two transitioned to standard operating procedures (SOPs) and exemplar accreditation models, facilitating collaborative working sessions overseen by the MRCT Center to establish standardized regional pathways. Digital transformation took center stage on day three, featuring live digital platform demonstrations from Zimbabwe and Tanzania.
Willyanne DeCormier Plosky of the MRCT Center led a dedicated financial sustainability workstream, introducing a prototype digital tracking dashboard designed to help national teams forecast revenue and operational expenses. Day four culminated in country-specific presentations outlining clear commitments for IRB training rollouts, updated codes of ethics, and joint grant funding applications.
Modernizing Governance and Clinical Compliance
Addressing these regulatory hurdles requires deep collaboration between public health agencies and specialized legal and clinical compliance networks. Delays in clinical trial initiation can disrupt the development of novel therapeutics and vaccines, underscoring the necessity for robust administrative frameworks.
As the TRACE initiative advances through its 2026 and 2027 milestones, the concerted focus on digital integration and financial autonomy establishes a resilient framework for future biomedical innovation across Sub-Saharan Africa.
*Disclaimer: The information provided in this article is for educational and scientific communication purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider regarding any medical condition, diagnosis, or treatment plan.*